IMOS
ChipMOS TECHNOLOGIES Inc.
IMOS lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
IMOS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Healthy |
IMOS's balance sheet is currently healthy. There isn't enough data to rate its revenue, profitability and cash flow.
IMOS PE Valuation
IMOS has no meaningful PE right now: it lost money over the past year.
IMOS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for IMOS, with profitability improving.
IMOS Earnings Per Share
IMOS Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | +13 points |
| Q1 2026 | 7.5% | +5.4 points |
| Q4 2025 | 9.7% | +7.5 points |
| Q3 2025 | 6% | -0.9 points |
| Q2 2025 | 0.4% | -6.1 points |
| Q1 2025 | 2.1% | -4.6 points |
| Q4 2024 | 2.2% | -10 points |
| Q3 2024 | 6.9% | -1.8 points |
IMOS's operating margin was 13% last quarter, up 12 points from the same quarter a year ago.
IMOS Free Cash Flow
IMOS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | -0.0x | Net Cash |
| Q3 2024 | 0.3x | Very low |
IMOS's net debt is less than a year of its operating earnings (EBITDA).
IMOS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.6 | Neutral |
| Stochastic | 17.0 | Oversold |
IMOS's weekly RSI is 47 (neutral) and its Stochastic is 17 (oversold).
IMOS PE vs Technology Sector
| Metric | IMOS | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 28x | 0.5% below |
| PE % | 85 | 35 | 50 pts above |
IMOS has no meaningful PE right now: it lost money over the past year.
IMOS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.4 | 19% below |
| 20 week MA | $60.3 | 16% below |
| 50 week MA | $50.0 | 1.4% above |
| 100 week MA | $34.6 | 47% above |
| 200 week MA | $29.7 | 71% above |
IMOS has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 71% above its 200-week average.
IMOS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.2 | $24.0 | +3.3% |
| 2021 | $24.0 | $34.7 | +44% |
| 2022 | $34.7 | $21.4 | -38% |
| 2023 | $21.4 | $27.2 | +27% |
| 2024 | $27.2 | $19.1 | -30% |
| 2025 | $19.1 | $30.3 | +58% |
| 2026 YTD | $30.3 | $50.7 | +68% |
IMOS has finished higher in four of the last six years. It's up 68% so far in 2026.